The latest price target for QuidelOrtho (NASDAQ:QDEL) was reported by RBC Capital on February 13, 2025. The analyst firm set a price target for $61.00 expecting QDEL to rise to within 12 months (a possible 51.16% upside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for QuidelOrtho (NASDAQ:QDEL) was provided by RBC Capital, and QuidelOrtho maintained their outperform rating.

The last upgrade for QuidelOrtho Corp happened on December 11, 2024 when Citigroup raised their price target to $50. Citigroup previously had a neutral for QuidelOrtho Corp.

The last downgrade for QuidelOrtho Corp happened on March 4, 2024 when UBS changed their price target from $70 to $42 for QuidelOrtho Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of QuidelOrtho, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for QuidelOrtho was filed on February 13, 2025 so you should expect the next rating to be made available sometime around February 13, 2026.

While ratings are subjective and will change, the latest QuidelOrtho (QDEL) rating was a maintained with a price target of $64.00 to $61.00. The current price QuidelOrtho (QDEL) is trading at is $40.35, which is out of the analyst’s predicted range.